Prime Medicine, Bristol Myers Squibb enter T-cell therapy pact potentially worth upward of $3.5 billion

To send an e-mail to multiple recipients, separate e-mail addresses with a comma, semicolon, or both.

Chemical & Engineering News will not share your email address with any other person or company.